Global Urology Devices Market 2025 – 2034

Reports Description

As per the Urology Devices Market analysis conducted by the BRI team, the urology devices market is expected to record a CAGR of 7.23% from 2025 to 2034. In 2025, the market size was USD 6.94 Billion. By 2034, the valuation is anticipated to reach USD 12.96 Billion.

Overview

Nephrology and urology devices imply medical equipment and tools used in diagnosis as well as treatment of ailments affecting the kidney and urinary system. The urologists are depending on various devices for performing surgeries, procedures, and diagnostic tests. Such devices have been designed for helping in procedures like removal of kidney stones, dialysis, bladder management, and collection of urine. They are necessary regarding improvement of patient outcomes, improving quality of life, and lessening the burden of urological and renal diseases.

Instances of urology devices include catheters, ureteral catheters, stone baskets, urinary stents, renal dilators, urology guidewires, hemodialysis machines, cystoscopes, urine analyzers, peritoneal dialysis machines, lithotripters, urodynamic systems, urological lasers, and prostate stents. Rising incidences of chronic kidney diseases, urinary incontinence, kidney stones, and urological cancers are driving demand for devices as well as treatments in urology and nephrology.

Key Trends & Drivers

• Rising Incidences of Urological Devices

The rising incidences of lifestyle-related and chronic diseases like cancer and diabetes are basically driving the urology devices market. Diagnostic testing does play a crucial role in disease management, detection, and monitoring. As such, it does boost the demand for precise and reliable urological diagnostic systems. Plus, emphasis on early diagnostics and preventive healthcare is encouraging implementation of the routine health screening programs, thereby propelling adoption of the urology devices in advanced form across clinics, dialysis centers, and hospitals. The factors mentioned above are collectively supporting the market growth. In April 2023, DaVita and Medtronic introduced Mozarc Medical Holding LLC (an independent company emphasizing patient-centered technology and kidney health solutions for improving patient experience and increasing access to care across the globe).

• Rising R&D Activities for Technological Advancements

The increased prevalence of several urological disorders – such as end-stage renal diseases, urolithiasis, and chronic kidney diseases has driven healthcare product manufacturers and personnel alike toward developing urology devices that are technologically advanced. Along these lines, Ethicon, Inc., in February 2023, did launch the very first robotics-assisted kidney stone removal using “Monarch.” This approach helps in reducing chances of repeated treatment, thereby reducing the complications further. Also, advancements in products that offer promise of better durability and visualization are anticipated to raise adoption of the urology devices at the global level.

What’s trending in the Urology Devices Market?

The advantages of single-use flexible cystoscopes are inclusive of reduced infection with no requirement of repairs or reprocessing. Plus, an upsurge in awareness on this count does stimulate manufacturers to increase clinical research and development for introducing disposable cystoscopes. Boston Scientific, in January 2024, did announce that it had introduced the VeraVue Single-Use Flexible cystoscope meant for helping the healthcare professionals to diagnose as well as treat the indications pertaining to the urinary tract. It also provides imaging of the bladder’s and urethra’s lining.

Key Threats

The urology devices market is visibly consolidated. In other words, it is dominated by the major players having a robust brand presence with significant R&D capacities. The structure of the market does present higher entry barriers owing to sizable capital investments needed for research and production. The established players are leveraging the adoption of technological advancements for maintaining competitiveness, whereas the new entrants do face challenges in having themselves differentiated. As such, higher costs and the need for infrastructure do remain prime obstacles to wider market adoption.

Opportunities

The emerging economies are likely to present stronger growth opportunities for the urology devices market owing to enhancement in healthcare infrastructure, expansion of patient bases, conducive regulations, and spending on healthcare. With supportive governments’ policies, especially in the Asia Pacific, the demand for advanced medical technologies is bound to witness exponentiation during the forecast period.

Category Wise Insights

By Production Type

• Endoscopes

Endourology relies on endoscopes such as uteroscopes and cystoscopes as they allow for procedures either through minute incisions or natural body openings, thereby reducing hospital stays, patient trauma, and recovery times as compared to conventional open surgery. Also, these devices do eliminate risk pertaining to cross-contamination linked with inappropriate sterilization of the reusable scopes. They also enhance procedural efficiency by enabling removal of the cost and time needed for reprocessing, maintenance, and repair, which lessens the waiting times of patients.

• Laser & Lithotripsy Devices

Lasers and lithotripsy devices do help in breaking stones or ablating tissue through endoscopes, thereby averting larger incisions resulting in blood loss, less pain, and faster healing. Shorter stays in the hospitals coupled with faster returns to normal activities appeal to a higher number of patients. Latest Thulium and Holmium fiber lasers do fragment stones more accurately and faster, thereby enhancing safety and efficiency. Innovations in the form of intracorporeal laser systems do offer higher stone-free rates, thereby replacing less efficient, older methods.

• Dialysis Devices

The increased cases of kidney failure and chronic kidney diseases (CKDs) do create a higher demand for dialysis, thereby boosting the market for associated urology devices. Dialysis centers come across as the major consumers of urology devices, wherein they could be used for both – management of long-term kidney issues and replacement therapy, thereby rendering them a discrete growth segment. Preference for home dialysis (self-catheterization and portable units) widens the market such that these devices are making their presence felt in the remote areas.

• Accessories

Consumable accessories (guidewires, catheters, and drainage bags) are single-use. They are creating steady, predictable demand as well as revenue streams. Accessories such as sheaths, dilators, and forceps enable removal of stones (lithotripsy) and endoscopic procedures, thereby raising the volumes of the procedures performed. Innovations like antimicrobial coatings or biodegradable stents do improve the comfort of patients.

By Application

• Urolithiasis

Urolithiasis treatment implies using less invasive methods like ureteroscopy and ESWL that need specialized tools such as lasers, flexible ureteroscopes, and fragmentation devices. Development of various advanced tools like robotic-assisted systems (such as the MONARCH platform by Johnson & Johnson), digital scopes, and laser lithotripsy improves recovery and precision, thereby driving adoption of new products. Disposable cystoscopes curtail the reprocessing time, thereby enhancing patient access and workflow.

• Urethral Malignancies

Cancers in the urethra (and bladder) need exact visualization, thereby driving the demand for better ureteroscopes, cystoscopies, and advanced imaging such as AI-powered ultrasound. Urethral malignancies do spur development in the robotic surgery systems (for minimally invasive, precise tumor removal), laser devices (for ablation followed by treatment of the cancerous issues), and implantable devices (in order to manage incontinence or support structures post-surgery). Treatment of urethral cancers does involve management of related issues such as incontinence or blockages, which, in turn, need devices such as stents, catheters, and urethral dilators.

• Bladder Disorders

Urinary incontinence (UI) does affect millions at the global scale, particularly women and the aged alike, thereby necessitating devices such as catheters, pads, and neuromodulation for management. Overactive bladder (OAB) could be treated with devices such as sacral neuromodulation (SNM) systems (such as Medtronic InterStim). The enlarged prostate does block the flow of urine, thereby resulting in the requirement of stents, pumps, and catheters. Conditions that result from nerve damage (such as spinal injuries, MS, and diabetes) require devices such as inflow pumps for emptying the bladder.

• Kidney Diseases

Rising prevalence of hypertension and diabetes is leading to impairment of kidneys, thereby boosting the demand for catheters, dialysis equipment (filters, machines, home dialysis), and management devices. Kidney stones need interventions such as stenting and lithotripsy, thereby raising demand for lasers, ureteroscopes, and specialized catheters (such as PCN catheters). Also, rising demand for renal replacement therapies such as dialysis does drive the sales of urology devices on direct basis.

By End-user

• Hospitals & Ambulatory Surgical Centers

Hospitals have well-established urology/nephrology departments and resources and are capable of handling complex surgeries (oncology, transplants), thereby appealing to large volumes of patients and asking for high-end, diverse devices (robotics, imaging). They do offer integrated care, right from cystoscopy to endoscopic tools, thereby pushing the manufacturers to supply and innovate such high-value systems. Ambulatory Surgical Centers (ASCs) are expanding owing to shorter waits, cost-effectiveness, and lower risks of infection, thereby rendering them ideal for various urological procedures.

• Dialysis Centers

Dialysis centers use huge quantities of disposables (tubing, filters, and dialysate) and capital equipment (machines) for routine care. The growing prevalence of CKD and kidney failure translates into a greater number of patients needing dialysis, thereby raising the patient base for such devices. The centers are pushing the manufacturers to develop various advanced solutions like efficient hemodialysis systems (for instance – high-volume hemodiafiltration) and portable dialysis units, thereby expanding the capabilities of the devices.

Historical Context

Urological diseases could be addressed through noninvasive techniques like ultrasound imaging, laser therapy, and alternative drugs. Such alternatives reduce demand for devices like endoscopes, dialysis machines, and urinary catheters for treating these diseases. The higher incidences of chronic kidney diseases (CKDs) coupled with a rising aging population at the global scale are amongst the high-impact drivers for the urology devices market. The National Kidney Foundation states that 10% of the global population is battling chronic kidney diseases.

Urology devices include urodynamic systems, laser & lithotripsy devices, urology robotic systems, Ureteroscopes, and cystoscopes, which are used for diagnosing bladder and urethra-related disorders. Technological advancements in the urology products are likely to accelerate the demand for such devices for treating the diseases mentioned above. Also, the demand for single-use cystoscopes is on the rise.

How is AI shaping the Urology Devices Market?

AI algorithms do analyse the complex imaging data obtained from CT scans, MRIs, and ultrasounds with higher precision and speed as compared to conventional methods. They improve characterization and detection of the urological cancers (such as bladder and prostate cancer) by identification of subtle patterns in the images that might be missed by the human clinicians.

AI algorithms help in grading the prostate cancer (Gleason score) from the biopsy samples, thereby reducing the variability amongst pathologists. They automate image annotation and segmentation for streamlining clinical workflows and reducing the workload of radiologists. The recently developed AI-powered real-time urine analysis device is being attached to the toilets for identifying biomarkers for UTIs and kidney stones.

How are the U.S. Tariffs affecting Urology Devices Market?

Tariffs on various parts as well as finished devices from India and China are raising expenses, thereby adversely affecting the entire chain – right from raw materials to the syringes. The manufacturers are either absorbing costs (reducing margins) or passing them on, thereby increasing healthcare costs. They are also exploring shifting the production to the U.S. for avoiding tariffs, finding novel materials or suppliers, or optimizing the regional manufacturing footprints. However, it would come with hurdles such as massive re-approval (such as FDA 510(k) for novel materials), thereby creating multi-year challenges.

Report Scope

Feature of the Report	Details
Market Size in 2025	USD 6.94 Billion
Projected Market Size in 2034	USD 12.96 Billion
Market Size in 2024	USD 6.47 Billion
CAGR Growth Rate	7.23% CAGR
Base Year	2024
Forecast Period	2025-2034
Key Segment	By Production Type, Application, End-user and Region
Report Coverage	Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope	North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options	Request tailored purchasing options to fulfil your requirements for research.

Regional Perspective

The urology devices market is classified into North America, Europe, Asia Pacific, and LAMEA.

• North America

North America holds over 30% of the market share and the status quo is expected to remain unchanged during the forecast period. This is credited to the growing prevalence of kidney-associated ailments, increased government initiatives regarding diverse treatment procedures, and well-established healthcare infrastructure in the U.S. and Canada. Also, the ongoing research funding for floating advanced devices is influencing the growth of the urology devices industry herein. Besides, rising incidences of hypertension and diabetes do increase the risk of contracting nephrology and urology diseases, which, in turn, are expected to expedite the urology devices market in the U.S. As per the U.S. Department of Health and Human Services, the year 2021 witnessed 1 in 7 U.S. adults fighting chronic kidney disease (CKD).

• Asia Pacific

The Asia Pacific is expected to witness the fastest CAGR in the urology devices market during the forecast period. This is due to a rise in awareness about urinary and kidney disorders, increased healthcare expenditure, and improvement in healthcare facilities herein. UTI is amongst the highly prevalent infectious diseases in the Asia Pacific. Plus, the need to develop the new systems along with the replacement and upgradation of the existing medical infrastructure is contributing toward the rising demand for such devices.

• Europe

Europe holds the second-largest market share, attributed to a huge patient pool battling urolithiasis, bladder disorders, and various other urology disorders. Also, an increase in the number of approvals regarding urology devices by the European Commission is expected to raise the adoption of urological devices all over Europe. Ambu A/S, in October 2023, announced the European regulatory clearance (CE mark) of its novel cystoscope called the Ambu aScope 5 Cysto HD in conjunction with the Ambu aView 2 Advance (the full-HD endoscopy system).

• LAMEA

The African-Middle Eastern population is reported to be prone to chronic kidney diseases (CKD) amongst the demographics worldwide. Research states that the rate of incidence of CKD amongst the African-Middle Eastern economies does stand at 18-23% of the global population. As per the International Diabetes Federation, 73 million adults lived with diabetes in the MENA region as of 2021. It further states that the number is likely to reach 136 million by the year 2045. The Latin American market for urology devices is likely to cross US$ 1.3 Bn by the year 2030. Brazil is one of the key growth engines, followed by Chile and Argentina contributing to local manufacturing and innovation.

Key Developments

The urology devices market is witnessing a notable organic and inorganic expansion. Some of the key developments include –

• In April 2025, BD introduced the Phasix ST Umbilical Hernia Patch (the first fully absorbable mesh designed for repair of umbilical hernia). This product has obtained FDA 510(k) clearance and uses a surgical technique identical to permanent mesh procedures, thereby making provision for more effective treatment of hernia.

• In November 2024, Boston Scientific completed the acquisition of Axonics, thereby improving its urology portfolio with advanced solutions for bowel and urinary dysfunction.

• In May 2023, Olympus introduced POWERSEAL Dealer/Divider in the EMEA region with the objective of enhancing ergonomics and surgical performance.

Leading Players

The urology devices market is highly niche. Some of the key players in the market include:

• Fresenius Medical Care AG & Co. KGaA
• Boston Scientific Corporation
• Becton Dickinson and Company
• Braun Melsungen AG
• Cardinal Health
• Olympus Corporation
• Intuitive Surgical
• Coloplast A/S
• Stryker Corporation
• Teleflex Incorporated
• Convatec Group PLC
• Medtronic PLC
• Others

These firms apply numerous strategies to enter the market, including innovations and mergers and acquisitions, as well as collaboration. The urology devices market is shaped by the presence of diversified players that compete based on product innovation, vertical integration, and cost efficiency.

The Urology Devices Market is segmented as follows:

By Production Type

• Endoscopes
  • Cystoscopes
    • Disposable
    • Reusable
  • Ureteroscopes
    • Disposable
    • Reusable
  • Other Endoscopes
• Laser & Lithotripsy Devices
• Dialysis Devices
• Accessories

By Application

• Urolithiasis
• Urethral Malignancies
• Bladder Disorders
• Kidney Diseases

By End-user

• Hospitals & Ambulatory Surgical Centers
• Dialysis Centers

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America

[embedsocial_reviews id=”d4ae80cffae3d938f997111953699a733c8e6f99″]